Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration (CDER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02462928
Recruitment Status : Active, not recruiting
First Posted : June 4, 2015
Last Update Posted : March 29, 2019
Sponsor:
Information provided by (Responsible Party):
Allergan

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 18, 2018
  Estimated Study Completion Date : May 31, 2019
  Certification/Extension First Submitted : March 25, 2019